These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 25142413)
1. Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases. Merzoug LB; Marie S; Satoh-Takayama N; Lesjean S; Albanesi M; Luche H; Fehling HJ; Di Santo JP; Vosshenrich CA Eur J Immunol; 2014 Nov; 44(11):3380-91. PubMed ID: 25142413 [TBL] [Abstract][Full Text] [Related]
2. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1. Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311 [TBL] [Abstract][Full Text] [Related]
3. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871 [TBL] [Abstract][Full Text] [Related]
4. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression. Glasner A; Isaacson B; Viukov S; Neuman T; Friedman N; Mandelboim M; Sexl V; Hanna JH; Mandelboim O Sci Rep; 2017 Oct; 7(1):13090. PubMed ID: 29026144 [TBL] [Abstract][Full Text] [Related]
5. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. Halfteck GG; Elboim M; Gur C; Achdout H; Ghadially H; Mandelboim O J Immunol; 2009 Feb; 182(4):2221-30. PubMed ID: 19201876 [TBL] [Abstract][Full Text] [Related]
6. NCR1-deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T-cell maturation. Miletic A; Lenartic M; Popovic B; Brizic I; Trsan T; Miklic K; Mandelboim O; Krmpotic A; Jonjic S Eur J Immunol; 2017 Sep; 47(9):1443-1456. PubMed ID: 28643847 [TBL] [Abstract][Full Text] [Related]
7. Dependence of innate lymphoid cell 1 development on NKp46. Wang Y; Dong W; Zhang Y; Caligiuri MA; Yu J PLoS Biol; 2018 Apr; 16(4):e2004867. PubMed ID: 29702643 [TBL] [Abstract][Full Text] [Related]
8. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Narni-Mancinelli E; Jaeger BN; Bernat C; Fenis A; Kung S; De Gassart A; Mahmood S; Gut M; Heath SC; Estellé J; Bertosio E; Vely F; Gastinel LN; Beutler B; Malissen B; Malissen M; Gut IG; Vivier E; Ugolini S Science; 2012 Jan; 335(6066):344-8. PubMed ID: 22267813 [TBL] [Abstract][Full Text] [Related]
9. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy. Bar-On Y; Charpak-Amikam Y; Glasner A; Isaacson B; Duev-Cohen A; Tsukerman P; Varvak A; Mandelboim M; Mandelboim O J Virol; 2017 Oct; 91(19):. PubMed ID: 28724773 [TBL] [Abstract][Full Text] [Related]
10. A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Eckelhart E; Warsch W; Zebedin E; Simma O; Stoiber D; Kolbe T; Rülicke T; Mueller M; Casanova E; Sexl V Blood; 2011 Feb; 117(5):1565-73. PubMed ID: 21127177 [TBL] [Abstract][Full Text] [Related]
11. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection. Diab M; Glasner A; Isaacson B; Bar-On Y; Drori Y; Yamin R; Duev-Cohen A; Danziger O; Zamostiano R; Mandelboim M; Jonjic S; Bacharach E; Mandelboim O Eur J Immunol; 2017 Apr; 47(4):692-703. PubMed ID: 28191644 [TBL] [Abstract][Full Text] [Related]
12. Conditional Genetic Ablation Mouse Models as a Tool to Study Cancer Immunosurveillance In Vivo. Dupont M; Vosshenrich CAJ Methods Mol Biol; 2019; 1884():161-176. PubMed ID: 30465202 [TBL] [Abstract][Full Text] [Related]
13. Expression of NK-Activating Receptor-NKp46/NCR1 on NK Cells in Patients with Severe Aplastic Anemia. Fu R; Liu H; Zhang J; Liu C; Ding S; Li L; Wang H; Wang G; Song J; Shao Z Clin Lab; 2015; 61(9):1221-9. PubMed ID: 26554241 [TBL] [Abstract][Full Text] [Related]
14. Lessons from NK Cell Deficiencies in the Mouse. Deauvieau F; Fenis A; Dalençon F; Burdin N; Vivier E; Kerdiles Y Curr Top Microbiol Immunol; 2016; 395():173-90. PubMed ID: 26385768 [TBL] [Abstract][Full Text] [Related]
15. Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection. Borst K; Flindt S; Blank P; Larsen PK; Chhatbar C; Skerra J; Spanier J; Hirche C; König M; Alanentalo T; Hafner M; Waibler Z; Pfeffer K; Sexl V; Sutter G; Müller W; Graalmann T; Kalinke U PLoS Pathog; 2020 Feb; 16(2):e1008279. PubMed ID: 32023327 [TBL] [Abstract][Full Text] [Related]
16. Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells. Satoh-Takayama N; Lesjean-Pottier S; Sawa S; Vosshenrich CA; Eberl G; Di Santo JP Eur J Immunol; 2011 Mar; 41(3):780-6. PubMed ID: 21341264 [TBL] [Abstract][Full Text] [Related]
17. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889 [TBL] [Abstract][Full Text] [Related]
18. NK Cell Recognition of Candida glabrata through Binding of NKp46 and NCR1 to Fungal Ligands Epa1, Epa6, and Epa7. Vitenshtein A; Charpak-Amikam Y; Yamin R; Bauman Y; Isaacson B; Stein N; Berhani O; Dassa L; Gamliel M; Gur C; Glasner A; Gomez C; Ben-Ami R; Osherov N; Cormack BP; Mandelboim O Cell Host Microbe; 2016 Oct; 20(4):527-534. PubMed ID: 27736647 [TBL] [Abstract][Full Text] [Related]
19. The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s. Sheppard S; Schuster IS; Andoniou CE; Cocita C; Adejumo T; Kung SKP; Sun JC; Degli-Esposti MA; Guerra N Cell Rep; 2018 Mar; 22(13):3385-3392. PubMed ID: 29590608 [TBL] [Abstract][Full Text] [Related]